×
About 6,628 results

ALLMedicine™ Cholera Center

Research & Reviews  1,971 results

Vaccine in Short Supply Amid Increased Cholera Outbreaks.
https://doi.org/10.1097/01.NAJ.0000919688.58866.9a
The American Journal of Nursing;

Jan 27th, 2023 - Natural and human-made disasters have contributed to the rise in cases.

Influence of Seasonal Hazards on Water, Sanitation, and Hygiene-Related Behavior and Im...
https://doi.org/10.4269/ajtmh.21-0708
The American Journal of Tropical Medicine and Hygiene; Lawrence Grant S, Lange S et. al.

Jan 24th, 2023 - Most cholera outbreaks in Bangladesh are seasonal, peaking in the dry and post-monsoon periods. Therefore, we investigated whether changes in water, sanitation, and hygiene (WASH) behavior in three populations in Bangladesh during the year could h...

The Pedunculopontine Tegmental Nucleus is not Important for Breathing Impairments Obser...
https://doi.org/10.1016/j.neuroscience.2022.12.022
Neuroscience Miranda NC, Oliveira LM et. al.

Jan 24th, 2023 - Parkinson's disease (PD) is a motor disorder resulting from degeneration of dopaminergic neurons of substantia nigra pars compacta (SNpc), with classical and non-classical symptoms such as respiratory instability. An important region for breathing...

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869508
BMC Public Health; Chisenga CC, Bosomprah S et. al.

Jan 24th, 2023 - Histo-blood group antigens (HBGAs) which include the ABO and Lewis antigen systems have been known for determining predisposition to infections. For instance, blood group O individuals have a higher risk of severe illness due to V. cholerae compar...

Cholera is back but the world is looking away.
https://doi.org/10.1136/bmj.p141
BMJ (Clinical Research Ed.); Khoury P

Jan 20th, 2023 - Cholera is back but the world is looking away.|2023|Khoury P,|epidemiology,prevention & control,

see more →

Guidelines  1 results

Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657988
MMWR. Morbidity and Mortality Weekly Report; Wong KK, Burdette E et. al.

May 12th, 2017 - Cholera, caused by infection with toxigenic Vibrio cholerae bacteria of serogroup O1 (>99% of global cases) or O139, is characterized by watery diarrhea that can be severe and rapidly fatal without prompt rehydration. Cholera is endemic in approxi...

see more →

Drugs  297 results see all →

Clinicaltrials.gov  110 results

Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test
https://clinicaltrials.gov/ct2/show/NCT05292508

Dec 28th, 2022 - The World Health Organization (WHO) defines antimicrobial resistance (AMR) as a situation where drugs used to treat microbial infection caused by bacteria, viruses, fungi and parasites no longer work to treat infection because of the changes in th...

First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers
https://clinicaltrials.gov/ct2/show/NCT05657782

Dec 20th, 2022 - The primary objectives of this study are: To evaluate the reactogenicity and the safety of a single-dose PanChol over a range of doses in healthy volunteers. To evaluate the immunogenicity of a single-dose PanChol over a range of doses as measured...

Management of Shock in Children With SAM or Severe Underweight and Diarrhea
https://clinicaltrials.gov/ct2/show/NCT04750070

Dec 20th, 2022 - Background: Burden: Burden: Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8% of 5.4 million global under-5 deaths. Co-morbidity of severe acute malnutrition (SAM) and shock in children with diarrhea is as...

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT05559983

Dec 5th, 2022 - A total of 150 eligible participants will be recruited in 3 sequential dose cohorts: low-dose 5 µg, medium-dose 10 µg, and high-dose 25 µg. In each dose cohorts, the participants will be randomized in a blinded manner into three arms (vaccine anti...

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon
https://clinicaltrials.gov/ct2/show/NCT03719066

Oct 5th, 2022 - This is an open label, randomized, phase 2 clinical trial of the immunogenicity of killed oral cholera vaccine (OCV) when the vaccine is administered to participants of three age cohorts (1-4 years, 5-14 years, and >14 years) and in three dose int...

see more →

News  262 results

7 Million Errors a Year in the ED; Corpses May Spread COVID; Lead in Dark Chocolate
https://www.medpagetoday.com/infectiousdisease/covid19/102273

Dec 16th, 2022 - Note that some links may require subscriptions. An estimated 5.7% patients are misdiagnosed in the emergency department (ED) each year, representing about 7.4 million errors, 2.6 million harms, and more than 370,000 patients suffering permanent di...

'We're Going to Be Free': Chinese Cheer as COVID Curbs Are Loosened
https://www.medscape.com/viewarticle/985160

Dec 8th, 2022 - BEIJING (Reuters) - China on Wednesday announced the most sweeping changes to its resolute anti-COVID regime since the pandemic began three years ago, loosening rules that curbed the spread of the virus but sparked protests and hobbled the world's...

China Eases COVID Quarantine Rules in Major Policy Adjustment
https://www.medscape.com/viewarticle/985159

Dec 8th, 2022 - BEIJING (Reuters) -China's national health authority said on Wednesday that asymptomatic COVID-19 cases and people with mild symptoms can quarantine at home, in the strongest sign yet that China is preparing its people to live with the disease. Mo...

China May Announce 10 New COVID Easing Steps on Wednesday: Sources
https://www.medscape.com/viewarticle/984972

Dec 6th, 2022 - HONG KONG (Reuters) - China may announce 10 new COVID-19 easing measures as early as Wednesday, two sources with knowledge of the matter told Reuters, supplementing 20 unveiled in November that set off a wave of COVID easing steps nationwide. Thre...

see more →

Patient Education  10 results see all →